About GEMINI THERAPEUTICS, INC
Gemini Therapeutics is a biopharmaceutical company focused on advancing aldoxorubicin, a tumor-targeted anthracycline chemotherapy, by providing the necessary capital and operational expertise to bring it to patients. The company was founded in 2022 by Sid Sijbrandij, who was diagnosed with osteosarcoma and sought a better treatment option.
Is this your company?
Claim GEMINI THERAPEUTICS, INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim GEMINI THERAPEUTICS, INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.